Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INDSWFTLAB | NSE
-3.16
-2.29%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
134.63
141.94
142.00
134.00
Ind-Swift Laboratories Limited develops manufactures and sells active pharmaceutical ingredients (APIs) and advanced intermediates in India. The company offers APIs in various therapeutic areas including macrolide antibiotic cardiovascular antihistaminic antidiabetic antipsychotic bone resorption inhibitor antimigraine Parkinson disease hyperparathyrodism analgesic aromatase inhibitor nootropic antidiarrhoeal/antiprotozoal anticholinergic sedative hypnotic and antineoplastic as well as various products for ADHD symptoms. It also provides reference standards and impurities for acamprosate calcium anastrozole aripiprazole aripiprazole atorvastatin calcium bexarotene cinacalcet hydrochloride clopidogrel bisulphate Clarithromycin ezetimibe fexofenadine hydrochloride imatinib mesylate ivabradine hydrochloride ivabradine oxalate letrozole mecloxamine citrate naratriptan hydrochloride nitazoxanide quetiapine ropinirole hydrochloride rosuvastatin calcium saxagliptin monohydrate silodosin and temozolomide as well as contract research and manufacturing services. The company also exports its products. The company was incorporated in 1995 and is headquartered in Manimajra India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
27.0%1 month
42.6%3 months
66.5%6 months
62.6%2.10
-
0.92
0.02
0.01
0.64
0.34
-
1.97B
7.95B
95.13M
-
-30.12
-94.50
-89.30
52.18
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
24.45
Range1M
34.94
Range3M
73.80
Rel. volume
0.37
Price X volume
9.03M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 265.52 | 8.70B | 4.80% | 16.51 | 416.89% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1459.65 | 8.33B | -1.33% | 10.74 | 0.87% |
Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 369.3 | 5.97B | -0.30% | 50.24 | 17.95% |
SAKAR | SAKAR | Drug Manufacturers-Specialty & Generic | 328.45 | 5.69B | 65.31 | 30.25% | |
Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 446.95 | 5.64B | -3.29% | 72.99 | 15.37% |
Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 109.43 | 5.37B | -2.85% | 31.56 | 45.58% |
Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 343.5 | 4.62B | -1.05% | 17.16 | 8.48% |
Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 153.56 | 4.03B | -2.00% | n/a | 8.60% |
Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 48 | 3.84B | 3.23% | 41.94 | 15.37% |
Par Drugs And Chemicals Limited | PAR | Drug Manufacturers-Specialty & Generic | 234.05 | 2.94B | -2.01% | 22.25 | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 102.27 | 3.27B | -3.96% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.64 | - | Cheaper |
Ent. to Revenue | 0.34 | - | Cheaper |
PE Ratio | 2.10 | 47.84 | Cheaper |
Price to Book | 0.92 | 6.55 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 66.50 | - | Riskier |
Debt to Equity | 0.02 | 0.34 | Cheaper |
Debt to Assets | 0.01 | 0.17 | Cheaper |
Market Cap | 7.95B | - | Emerging |